[Morvan's fibrillary chorea in patients on chrysotherapy for rheumatoid polyarthritis].
Masson
C
C
Clinique de Rhumatologie, CHU d'Angers.
Renier
J C
JC
Robert
C
C
Emile
J
J
Brégeon
C
C
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002819:Chorea / Q000139:chemically induced*; D004112:Dimercaprol / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006046:Gold / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008667:Metalloproteins / Q000009:adverse effects*; D008875:Middle Aged; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds
D008667:Metalloproteins; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds; D004112:Dimercaprol; D006046:Gold; C013394:aurotioprol
Chorée fibrillaire de Morvan chez des patients sous chrysothérapie pour une polyarthrite rhumatoïde.